
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Respiri Limited is a medical devices business based in Australia. Respiri shares (RSH) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Respiri has a trailing 12-month revenue of around $1.2 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.059 - $0.25 |
---|---|
50-day moving average | $0.1329 |
200-day moving average | $0.1643 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.017 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Revenue TTM | $1.2 million |
---|---|
Gross profit TTM | $2.2 million |
Return on assets TTM | -108.65% |
Return on equity TTM | -219.14% |
Profit margin | 0% |
Book value | 0.016 |
Market capitalisation | $90.3 million |
TTM: trailing 12 months
We're not expecting Respiri to pay a dividend over the next 12 months.
Respiri 's shares were split on a 1:20 basis on 30 July 2012. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Respiri shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Respiri shares which in turn could have impacted Respiri 's share price.
Over the last 12 months, Respiri 's shares have ranged in value from as little as $0.059 up to $0.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Respiri 's is -0.2043. This would suggest that Respiri 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Respiri has bucked the trend.
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
Beat the banks, find the best exchange rates and avoid fees when you send money abroad from Australia.
All the key info you need to know to sell shares you inherited or received as a gift.
Steps to owning and managing Roblox shares.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Steps to owning and managing Zebit shares.
Steps to owning and managing CleanSpace shares.